Therapy News and Research

RSS

Scientists positively influence immune response in viral and bacterial co-infection

Researchers from Charité - Universitätsmedizin Berlin were able to positively influence the immune response in severe viral and bacterial co-infection.

13 Jul 2017

Targeting immune cells could lead to new treatments for pulmonary fibrosis

Northwestern Medicine scientists have demonstrated that a unique population of immune cells plays a key role in the development of pulmonary fibrosis, and showed that targeting such cells could lead to new treatments for the disease.

13 Jul 2017

Research identifies opportunities to improve performance of clinicians during emergency events

Anesthesiology has a long history of scrutinizing its practice and developing strategies for improvement. In a recent prospective, observational study, 263 board-certified anesthesiologists from across the United States volunteered to participate as part of already scheduled continuing education simulation courses that focused on the management of life-threatening events.

13 Jul 2017

Nursing homes move into the insurance business

Around the country, a handful of nursing home companies have begun selling their own private Medicare insurance policies, pledging close coordination and promising to give clinicians more authority to decide what treatments they will cover for each patient.

13 Jul 2017

Cord-blood-derived natural killer cells can be modified to destroy B-cell cancers

Immune cells with a general knack for recognizing and killing many types of infected or abnormal cells also can be engineered to hunt down cells with specific targets on them to treat cancer, researchers at The University of Texas MD Anderson Cancer Center report in the journal Leukemia.

13 Jul 2017

Study demonstrates potential nanoparticle-based therapeutic strategy for deadly brain tumors

Early phase Northwestern Medicine research has demonstrated a potential new therapeutic strategy for treating deadly glioblastoma brain tumors.

13 Jul 2017

FDA advisory committee recommends Novartis' CAR-T therapy for young leukemia patients

Today the FDA's Oncologic Drugs Advisory Committee, an independent panel of experts, voted unanimously to recommend to the FDA approval of Novartis' experimental CAR-T therapy called Tisagenlecleucel, also known as CTL019.

13 Jul 2017

Bone metastasis-targeting drug shows potential as new therapeutic strategy for osteosarcoma

The treatment of osteosarcoma, the most common tumor of bone, is challenging. A study led by The University of Texas MD Anderson Cancer Center found a drug known as bone metastasis-targeting peptidomimetic (BMTP-11) has potential as a new therapeutic strategy for this devastating illness.

13 Jul 2017

New partnership to advance novel airway-delivered gene therapy for treating pulmonary hypertension

Mount Sinai has partnered with Theragene Pharmaceuticals, Inc. to advance a novel airway-delivered gene therapy for treating pulmonary hypertension (PH), a form of high blood pressure in blood vessels in the lungs that is linked to heart failure.

13 Jul 2017

Stroke recovery may be delayed up to decades after injury, study shows

Stroke survivors may experience delayed recovery of limb function up to decades after injury, according to a new case study. The article, published ahead of print in the Journal of Neurophysiology, was chosen as an APSselect article for July.

12 Jul 2017

Novel approach to leukemia therapy can safely improve treatment success, reduce side effects

New University of Liverpool research, presented at an international conference, confirms that a novel approach to the treatment of chronic myeloid leukemia (CML) can safely increase treatment success and reduce negative side effects.

12 Jul 2017

Novel approach could offer hope in treatment of inflammatory conditions

The team, led by researchers at Imperial College London, Queen Mary University of London and Ergon Pharmaceuticals, believes the approach could offer new hope in the treatment of inflammatory conditions like arthritis, autoimmune diseases, and sepsis.

12 Jul 2017

UAB improves dry eye treatment with development of new guidelines and expansion of clinic

Clinical practice and research of dry eye relief in the University of Alabama at Birmingham School of Optometry is progressing with the development and release of new guidelines for diagnosis and treatment of dry eye, as well as the expansion of services offered by the UAB Dry Eye Relief Clinic.

11 Jul 2017

New DNA-based vaccine protects testes, sperm from Zika-related damage in mouse models

While the Zika virus is primarily transmitted by mosquitoes, research has shown that the disease can affect semen and sperm and can therefore be spread through sexual intercourse.

11 Jul 2017

Tulane University receives $12 million NIH grant to develop drug and vaccine against Lassa fever

The National Institutes of Health has awarded Tulane University more than $12 million to test a promising drug treatment against Lassa fever and develop a vaccine against the deadly disease endemic in parts of West Africa.

11 Jul 2017

Novel therapy rapidly and effectively reverses effect of oral blood thinner

At least 28 million prescriptions for blood thinners are filled by pharmacists yearly for the irregular heartbeat of atrial fibrillation, deep vein thrombosis, and other indications, according to the Department of Health and Human Services.

11 Jul 2017

Using Modern Technology to Gamify Medication Adherence

Medication nonadherence is the phenomenon of people not sticking to their medication. Either stopping completely before they're supposed to, or taking it irregularly, at such a rate that it's below the optimal level.

From Perx Health 11 Jul 2017

Synthetic compound that reads mitochondrial DNA could lead to treatments for nerve, muscle diseases

For the first time, a synthetic compound has been made that can bind to DNA in the cells' energy powerhouses, suppressing a gene associated with nerve and muscle disease.

11 Jul 2017

Scientists develop potential new therapy for targeting skin cancer metastases in the brain

Investigators from Brigham and Women's Hospital (BWH) and the Harvard Stem Cell Institute have a potential solution for how to kill tumor cells that have metastasized to the brain.

10 Jul 2017

Millions of kids fall outside Senate plan to shield disabled from Medicaid cuts

Aidan Long is a 13-year-old from Kalispell, Mont., who has suffered multiple daily seizures since he was 4. The seizures defy medical cure, and some of them continue for weeks, requiring Aidan to be airlifted to children's hospitals in Denver or Seattle, said his father, Ben Long.

10 Jul 2017

Therapy News and Research

Scientists positively influence immune response in viral and bacterial co-infection

Targeting immune cells could lead to new treatments for pulmonary fibrosis

Research identifies opportunities to improve performance of clinicians during emergency events

Nursing homes move into the insurance business

Cord-blood-derived natural killer cells can be modified to destroy B-cell cancers

Study demonstrates potential nanoparticle-based therapeutic strategy for deadly brain tumors

FDA advisory committee recommends Novartis' CAR-T therapy for young leukemia patients

Bone metastasis-targeting drug shows potential as new therapeutic strategy for osteosarcoma

New partnership to advance novel airway-delivered gene therapy for treating pulmonary hypertension

Stroke recovery may be delayed up to decades after injury, study shows

Novel approach to leukemia therapy can safely improve treatment success, reduce side effects

Novel approach could offer hope in treatment of inflammatory conditions

UAB improves dry eye treatment with development of new guidelines and expansion of clinic

New DNA-based vaccine protects testes, sperm from Zika-related damage in mouse models

Tulane University receives $12 million NIH grant to develop drug and vaccine against Lassa fever

Novel therapy rapidly and effectively reverses effect of oral blood thinner

Using Modern Technology to Gamify Medication Adherence

Synthetic compound that reads mitochondrial DNA could lead to treatments for nerve, muscle diseases

Scientists develop potential new therapy for targeting skin cancer metastases in the brain

Millions of kids fall outside Senate plan to shield disabled from Medicaid cuts

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News